Report cover image

Global Adrenocorticotropic Hormone Receptor Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 193 Pages
SKU # APRC20560889

Description

Summary

According to APO Research, The global Adrenocorticotropic Hormone Receptor market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Adrenocorticotropic Hormone Receptor is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Adrenocorticotropic Hormone Receptor is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Adrenocorticotropic Hormone Receptor is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Adrenocorticotropic Hormone Receptor is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Adrenocorticotropic Hormone Receptor include Pfizer Inc., XOMA Corporation, Retrophin Inc., Mallinckrodt Plc, Ipsen S.A. and Alder Biopharmaceuticals Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes


This report presents an overview of global market for Adrenocorticotropic Hormone Receptor, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Adrenocorticotropic Hormone Receptor, also provides the revenue of main regions and countries. Of the upcoming market potential for Adrenocorticotropic Hormone Receptor, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Adrenocorticotropic Hormone Receptor revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Adrenocorticotropic Hormone Receptor market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Adrenocorticotropic Hormone Receptor revenue, projected growth trends, production technology, application and end-user industry.

Adrenocorticotropic Hormone Receptor Segment by Company

Pfizer Inc.
XOMA Corporation
Retrophin Inc.
Mallinckrodt Plc
Ipsen S.A.
Alder Biopharmaceuticals Inc.
Adrenocorticotropic Hormone Receptor Segment by Type

Corticotropin
BIM-23B065
AQB-565
Others
Adrenocorticotropic Hormone Receptor Segment by Application

Acromegaly
Cushing Disease
Hormonal Disorder
Musculoskeletal Disorder
Others
Adrenocorticotropic Hormone Receptor Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Adrenocorticotropic Hormone Receptor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Adrenocorticotropic Hormone Receptor and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Adrenocorticotropic Hormone Receptor.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Adrenocorticotropic Hormone Receptor in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Adrenocorticotropic Hormone Receptor company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Adrenocorticotropic Hormone Receptor revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

193 Pages
1 Market Overview
1.1 Product Definition
1.2 Adrenocorticotropic Hormone Receptor Market by Type
1.2.1 Global Adrenocorticotropic Hormone Receptor Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Corticotropin
1.2.3 BIM-23B065
1.2.4 AQB-565
1.2.5 Others
1.3 Adrenocorticotropic Hormone Receptor Market by Application
1.3.1 Global Adrenocorticotropic Hormone Receptor Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Acromegaly
1.3.3 Cushing Disease
1.3.4 Hormonal Disorder
1.3.5 Musculoskeletal Disorder
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Adrenocorticotropic Hormone Receptor Market Dynamics
2.1 Adrenocorticotropic Hormone Receptor Industry Trends
2.2 Adrenocorticotropic Hormone Receptor Industry Drivers
2.3 Adrenocorticotropic Hormone Receptor Industry Opportunities and Challenges
2.4 Adrenocorticotropic Hormone Receptor Industry Restraints
3 Global Growth Perspective
3.1 Global Adrenocorticotropic Hormone Receptor Market Perspective (2020-2031)
3.2 Global Adrenocorticotropic Hormone Receptor Growth Trends by Region
3.2.1 Global Adrenocorticotropic Hormone Receptor Market Size by Region: 2020 VS 2024 VS 2031
3.2.2 Global Adrenocorticotropic Hormone Receptor Market Size by Region (2020-2025)
3.2.3 Global Adrenocorticotropic Hormone Receptor Market Size by Region (2026-2031)
4 Competitive Landscape by Players
4.1 Global Adrenocorticotropic Hormone Receptor Revenue by Players
4.1.1 Global Adrenocorticotropic Hormone Receptor Revenue by Players (2020-2025)
4.1.2 Global Adrenocorticotropic Hormone Receptor Revenue Market Share by Players (2020-2025)
4.1.3 Global Adrenocorticotropic Hormone Receptor Players Revenue Share Top 10 and Top 5 in 2024
4.2 Global Adrenocorticotropic Hormone Receptor Key Players Ranking, 2023 VS 2024 VS 2025
4.3 Global Adrenocorticotropic Hormone Receptor Key Players Headquarters & Area Served
4.4 Global Adrenocorticotropic Hormone Receptor Players, Product Type & Application
4.5 Global Adrenocorticotropic Hormone Receptor Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global Adrenocorticotropic Hormone Receptor Market CR5 and HHI
4.6.3 2024 Adrenocorticotropic Hormone Receptor Tier 1, Tier 2, and Tier 3
5 Adrenocorticotropic Hormone Receptor Market Size by Type
5.1 Global Adrenocorticotropic Hormone Receptor Revenue by Type (2020 VS 2024 VS 2031)
5.2 Global Adrenocorticotropic Hormone Receptor Revenue by Type (2020-2031)
5.3 Global Adrenocorticotropic Hormone Receptor Revenue Market Share by Type (2020-2031)
6 Adrenocorticotropic Hormone Receptor Market Size by Application
6.1 Global Adrenocorticotropic Hormone Receptor Revenue by Application (2020 VS 2024 VS 2031)
6.2 Global Adrenocorticotropic Hormone Receptor Revenue by Application (2020-2031)
6.3 Global Adrenocorticotropic Hormone Receptor Revenue Market Share by Application (2020-2031)
7 Company Profiles
7.1 Pfizer Inc.
7.1.1 Pfizer Inc. Comapny Information
7.1.2 Pfizer Inc. Business Overview
7.1.3 Pfizer Inc. Adrenocorticotropic Hormone Receptor Revenue and Gross Margin (2020-2025)
7.1.4 Pfizer Inc. Adrenocorticotropic Hormone Receptor Product Portfolio
7.1.5 Pfizer Inc. Recent Developments
7.2 XOMA Corporation
7.2.1 XOMA Corporation Comapny Information
7.2.2 XOMA Corporation Business Overview
7.2.3 XOMA Corporation Adrenocorticotropic Hormone Receptor Revenue and Gross Margin (2020-2025)
7.2.4 XOMA Corporation Adrenocorticotropic Hormone Receptor Product Portfolio
7.2.5 XOMA Corporation Recent Developments
7.3 Retrophin Inc.
7.3.1 Retrophin Inc. Comapny Information
7.3.2 Retrophin Inc. Business Overview
7.3.3 Retrophin Inc. Adrenocorticotropic Hormone Receptor Revenue and Gross Margin (2020-2025)
7.3.4 Retrophin Inc. Adrenocorticotropic Hormone Receptor Product Portfolio
7.3.5 Retrophin Inc. Recent Developments
7.4 Mallinckrodt Plc
7.4.1 Mallinckrodt Plc Comapny Information
7.4.2 Mallinckrodt Plc Business Overview
7.4.3 Mallinckrodt Plc Adrenocorticotropic Hormone Receptor Revenue and Gross Margin (2020-2025)
7.4.4 Mallinckrodt Plc Adrenocorticotropic Hormone Receptor Product Portfolio
7.4.5 Mallinckrodt Plc Recent Developments
7.5 Ipsen S.A.
7.5.1 Ipsen S.A. Comapny Information
7.5.2 Ipsen S.A. Business Overview
7.5.3 Ipsen S.A. Adrenocorticotropic Hormone Receptor Revenue and Gross Margin (2020-2025)
7.5.4 Ipsen S.A. Adrenocorticotropic Hormone Receptor Product Portfolio
7.5.5 Ipsen S.A. Recent Developments
7.6 Alder Biopharmaceuticals Inc.
7.6.1 Alder Biopharmaceuticals Inc. Comapny Information
7.6.2 Alder Biopharmaceuticals Inc. Business Overview
7.6.3 Alder Biopharmaceuticals Inc. Adrenocorticotropic Hormone Receptor Revenue and Gross Margin (2020-2025)
7.6.4 Alder Biopharmaceuticals Inc. Adrenocorticotropic Hormone Receptor Product Portfolio
7.6.5 Alder Biopharmaceuticals Inc. Recent Developments
8 North America
8.1 North America Adrenocorticotropic Hormone Receptor Revenue (2020-2031)
8.2 North America Adrenocorticotropic Hormone Receptor Revenue by Type (2020-2031)
8.2.1 North America Adrenocorticotropic Hormone Receptor Revenue by Type (2020-2025)
8.2.2 North America Adrenocorticotropic Hormone Receptor Revenue by Type (2026-2031)
8.3 North America Adrenocorticotropic Hormone Receptor Revenue Share by Type (2020-2031)
8.4 North America Adrenocorticotropic Hormone Receptor Revenue by Application (2020-2031)
8.4.1 North America Adrenocorticotropic Hormone Receptor Revenue by Application (2020-2025)
8.4.2 North America Adrenocorticotropic Hormone Receptor Revenue by Application (2026-2031)
8.5 North America Adrenocorticotropic Hormone Receptor Revenue Share by Application (2020-2031)
8.6 North America Adrenocorticotropic Hormone Receptor Revenue by Country
8.6.1 North America Adrenocorticotropic Hormone Receptor Revenue by Country (2020 VS 2024 VS 2031)
8.6.2 North America Adrenocorticotropic Hormone Receptor Revenue by Country (2020-2025)
8.6.3 North America Adrenocorticotropic Hormone Receptor Revenue by Country (2026-2031)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Adrenocorticotropic Hormone Receptor Revenue (2020-2031)
9.2 Europe Adrenocorticotropic Hormone Receptor Revenue by Type (2020-2031)
9.2.1 Europe Adrenocorticotropic Hormone Receptor Revenue by Type (2020-2025)
9.2.2 Europe Adrenocorticotropic Hormone Receptor Revenue by Type (2026-2031)
9.3 Europe Adrenocorticotropic Hormone Receptor Revenue Share by Type (2020-2031)
9.4 Europe Adrenocorticotropic Hormone Receptor Revenue by Application (2020-2031)
9.4.1 Europe Adrenocorticotropic Hormone Receptor Revenue by Application (2020-2025)
9.4.2 Europe Adrenocorticotropic Hormone Receptor Revenue by Application (2026-2031)
9.5 Europe Adrenocorticotropic Hormone Receptor Revenue Share by Application (2020-2031)
9.6 Europe Adrenocorticotropic Hormone Receptor Revenue by Country
9.6.1 Europe Adrenocorticotropic Hormone Receptor Revenue by Country (2020 VS 2024 VS 2031)
9.6.2 Europe Adrenocorticotropic Hormone Receptor Revenue by Country (2020-2025)
9.6.3 Europe Adrenocorticotropic Hormone Receptor Revenue by Country (2026-2031)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Netherlands
10 China
10.1 China Adrenocorticotropic Hormone Receptor Revenue (2020-2031)
10.2 China Adrenocorticotropic Hormone Receptor Revenue by Type (2020-2031)
10.2.1 China Adrenocorticotropic Hormone Receptor Revenue by Type (2020-2025)
10.2.2 China Adrenocorticotropic Hormone Receptor Revenue by Type (2026-2031)
10.3 China Adrenocorticotropic Hormone Receptor Revenue Share by Type (2020-2031)
10.4 China Adrenocorticotropic Hormone Receptor Revenue by Application (2020-2031)
10.4.1 China Adrenocorticotropic Hormone Receptor Revenue by Application (2020-2025)
10.4.2 China Adrenocorticotropic Hormone Receptor Revenue by Application (2026-2031)
10.5 China Adrenocorticotropic Hormone Receptor Revenue Share by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Adrenocorticotropic Hormone Receptor Revenue (2020-2031)
11.2 Asia Adrenocorticotropic Hormone Receptor Revenue by Type (2020-2031)
11.2.1 Asia Adrenocorticotropic Hormone Receptor Revenue by Type (2020-2025)
11.2.2 Asia Adrenocorticotropic Hormone Receptor Revenue by Type (2026-2031)
11.3 Asia Adrenocorticotropic Hormone Receptor Revenue Share by Type (2020-2031)
11.4 Asia Adrenocorticotropic Hormone Receptor Revenue by Application (2020-2031)
11.4.1 Asia Adrenocorticotropic Hormone Receptor Revenue by Application (2020-2025)
11.4.2 Asia Adrenocorticotropic Hormone Receptor Revenue by Application (2026-2031)
11.5 Asia Adrenocorticotropic Hormone Receptor Revenue Share by Application (2020-2031)
11.6 Asia Adrenocorticotropic Hormone Receptor Revenue by Country
11.6.1 Asia Adrenocorticotropic Hormone Receptor Revenue by Country (2020 VS 2024 VS 2031)
11.6.2 Asia Adrenocorticotropic Hormone Receptor Revenue by Country (2020-2025)
11.6.3 Asia Adrenocorticotropic Hormone Receptor Revenue by Country (2026-2031)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Adrenocorticotropic Hormone Receptor Revenue (2020-2031)
12.2 SAMEA Adrenocorticotropic Hormone Receptor Revenue by Type (2020-2031)
12.2.1 SAMEA Adrenocorticotropic Hormone Receptor Revenue by Type (2020-2025)
12.2.2 SAMEA Adrenocorticotropic Hormone Receptor Revenue by Type (2026-2031)
12.3 SAMEA Adrenocorticotropic Hormone Receptor Revenue Share by Type (2020-2031)
12.4 SAMEA Adrenocorticotropic Hormone Receptor Revenue by Application (2020-2031)
12.4.1 SAMEA Adrenocorticotropic Hormone Receptor Revenue by Application (2020-2025)
12.4.2 SAMEA Adrenocorticotropic Hormone Receptor Revenue by Application (2026-2031)
12.5 SAMEA Adrenocorticotropic Hormone Receptor Revenue Share by Application (2020-2031)
12.6 SAMEA Adrenocorticotropic Hormone Receptor Revenue by Country
12.6.1 SAMEA Adrenocorticotropic Hormone Receptor Revenue by Country (2020 VS 2024 VS 2031)
12.6.2 SAMEA Adrenocorticotropic Hormone Receptor Revenue by Country (2020-2025)
12.6.3 SAMEA Adrenocorticotropic Hormone Receptor Revenue by Country (2026-2031)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.